Yohan Suryo Rahmanto
Yohan Suryo Rahmanto
The Johns Hopkins University, School of Medicine
Verified email at
Cited by
Cited by
Iron uptake and metabolism in the new millennium
LL Dunn, Y Suryo Rahmanto, DR Richardson
Trends in cell biology 17 (2), 93-100, 2007
Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol
DR Richardson, DJR Lane, EM Becker, MLH Huang, M Whitnall, ...
Proceedings of the National Academy of Sciences 107 (24), 10775-10782, 2010
Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant
MLH Huang, EM Becker, M Whitnall, Y Suryo Rahmanto, P Ponka, ...
Proceedings of the National Academy of Sciences 106 (38), 16381-16386, 2009
Hepcidin, the hormone of iron metabolism, is bound specifically to α-2-macroglobulin in blood
G Peslova, J Petrak, K Kuzelova, I Hrdy, P Halada, PW Kuchel, S Soe-Lin, ...
Blood 113 (24), 6225-6236, 2009
Iron chelators for the treatment of cancer
Y Yu, E Gutierrez, Z Kovacevic, F Saletta, P Obeidy, Y Suryo Rahmanto, ...
Current medicinal chemistry 19 (17), 2689-2702, 2012
Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis
B Guan, Y Suryo Rahmanto, RC Wu, Y Wang, Z Wang, TL Wang, IM Shih
JNCI: Journal of the National Cancer Institute 106 (7), dju146, 2014
The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation
M Whitnall, Y Suryo Rahmanto, R Sutak, X Xu, EM Becker, MR Mikhael, ...
Proceedings of the National Academy of Sciences 105 (28), 9757-9762, 2008
Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti‐tumour efficacy
Y Yu, Y Suryo Rahmanto, DR Richardson
British journal of pharmacology 165 (1), 148-166, 2012
Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy
Y Park, MH Chui, Y Suryo Rahmanto, ZC Yu, RA Shamanna, MA Bellani, ...
Clinical Cancer Research 25 (18), 5584-5594, 2019
The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis
LL Dunn, EO Sekyere, Y Suryo Rahmanto, DR Richardson
Carcinogenesis 27 (11), 2157-2169, 2006
Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia
M Whitnall, Y Suryo Rahmanto, MLH Huang, F Saletta, HC Lok, ...
Proceedings of the National Academy of Sciences 109 (50), 20590-20595, 2012
The medicinal chemistry of novel iron chelators for the treatment of cancer
Z Kovacevic, D S Kalinowski, D B Lovejoy, Y Yu, Y Suryo Rahmanto, ...
Current topics in medicinal chemistry 11 (5), 483-499, 2011
Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1α and p53
F Saletta, Y Suryo Rahmanto, E Noulsri, DR Richardson
Molecular pharmacology 77 (3), 443-458, 2010
Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins
Y Suryo Rahmanto, DS Kalinowski, DJR Lane, HC Lok, V Richardson, ...
Journal of Biological Chemistry 287 (10), 6960-6968, 2012
The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia
DR Richardson, MLH Huang, M Whitnall, EM Becker, P Ponka, ...
Journal of molecular medicine 88 (4), 323-329, 2010
The translational regulator eIF3a: the tricky eIF3 subunit!
F Saletta, Y Suryo Rahmanto, DR Richardson
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1806 (2), 275-286, 2010
N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
DJR Lane, F Saletta, Y Suryo Rahmanto, Z Kovacevic, DR Richardson
PloS one 8 (2), e57273, 2013
The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark–from iron metabolism to tumorigenesis
Y Suryo Rahmanto, LL Dunn, DR Richardson
Oncogene 26 (42), 6113-6124, 2007
Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes
HC Lok, Y Suryo Rahmanto, CL Hawkins, DS Kalinowski, CS Morrow, ...
Journal of Biological Chemistry 287 (1), 607-618, 2012
Therapeutic inducers of apoptosis in ovarian cancer
M Binju, MA Amaya-Padilla, G Wan, H Gunosewoyo, Y Suryo Rahmanto, ...
Cancers 11 (11), 1786, 2019
The system can't perform the operation now. Try again later.
Articles 1–20